Angela J. Waanders

Northwestern University — United States

Medicine · Health Sciences

29h-index6.8kcitations190works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(100), Neuroblastoma Research and Treatments(46), Cancer Genomics and Diagnostics(20), Protein Degradation and Inhibitors(13), Pancreatic and Hepatic Oncology Research(10)

Publications188 total

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors
Nature Communications·2025Open Access
Role of repulsive guidance signaling and GPR180 in pediatric low-grade glioma infiltration
npj Precision Oncology·2025Open Access
CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial
Neuro-Oncology·2025Open Access
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
UNC Libraries·2025Open Access
Post hoc analysis of rashes reported in patients (pts) with <i>BRAF</i> -altered relapsed/refractory (r/r) pediatric low-grade glioma (pLGG) treated with the type II RAF inhibitor tovorafenib in FIREFLY-1.
Journal of Clinical Oncology·2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Nature Medicine·2025Open Access
A New Logic for Pediatric Brain Tumor Segmentation
2025· 2 cited
Novel SMARCA4 Variant in an Infant With Atypical Teratoid Rhabdoid Tumor
Journal of Pediatric Hematology/Oncology·2025· 1 citedOpen Access
Baseline ophthalmic findings and complications in pediatric patients treated with MEK inhibitors
Journal of American Association for Pediatric Ophthalmology and Strabismus·2025· 1 citedOpen Access
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors
2025Open Access
Genetic ancestry superpopulations show distinct prevalence and outcomes across pediatric central nervous system tumors from the Pediatric Brain Tumor Atlas and Pediatric Neuro-Oncology Consortium
Neuro-Oncology·2025· 2 citedOpen Access
Editor’s Note: BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas
Clinical Cancer Research·2024Open Access
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors
Pediatric Blood & Cancer·2024Open Access
A New Logic For Pediatric Brain Tumor Segmentation
arXiv (Cornell University)·2024· 1 citedOpen Access
CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL
Neuro-Oncology·2024Open Access
NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)
Neuro-Oncology·2024Open Access
CTNI-78. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)
Neuro-Oncology·2024· 1 citedOpen Access
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant
Cancer Cell·2024· 40 citedOpen Access
“Socioeconomic factors associated with participation in post-mortem tissue donation in pediatric central nervous system (CNS) tumors”
2024Open Access
LGG-37. A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA
Neuro-Oncology·2024Open Access
page 1 of 10Next →

Frequent Co-authors

Adam Resnick(31), Phillip B. Storm(20), Pichai Raman(12), Mariarita Santi(12), Payal Jain(12), Marilyn M. Li(11), Sabine Mueller(11), Kristina A. Cole(11), Yuankun Zhu(10), Jena Lilly(10), Lea F. Surrey(9), Javad Nazarian(9), Cassie Kline(9), Allison P. Heath(8), Olaf Witt(7), Jennifer L. Mason(7), Sarah Leary(7), Jo Lynne Rokita(7), Brian R. Rood(7), David Jones(6)